Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways ...
A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in ...
The central image depicts currently used strategies for clinical targeting of TGF-β. Below are methods applicable from preclinical screening to clinical practice, including using humanized mouse ...
Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they typically work for only 40% to 80% of the patients who would be expected to ...
Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one of its deadliest features remains poorly understood: how tumor cells break ...
A newly identified interaction between ovarian cancer cells and surrounding abdominal cells helps explain the cancer’s ...
JCO Precision Oncology Conversations features discussions with leading authors of JCO Precision Oncology articles, hosted by Dr. Abdul Rafeh Naqash. Join our experts in engaging conversations as they ...
Colorectal tumors that underwent somatic next-generation sequencing (NGS) for 154-168 genes in an in-house laboratory between 2015 and 2022 were retrospectively identified. Microsatellite instability ...